We invest in frontier neuro. Check our podcast https://nitter.cf/t.co/LO4pYjLWjB
Joined July 2021
- Tweets302
- Following2
- Followers1.3K
- Likes151
Shahin built chips that read the brain for his PhD, then spent 20 years funding chips, sensors, and AI. Now it all points back to the brain!
Shahin Farshchi at Lux Capital likes to say neural interfaces have been "5 years away" for 20 years. So what's changed?
He joins us on Business Trip to discuss opportunities in neuro.
We get into his BCI investing framework, voice as an interface, and how he spots the next tech wave early.
businesstrip.fm/1173518/epis…
@Farshchi @Lux_Capital
PsyMed founding partner @matisere presented at @raiseconference this year. Few would have bet a few years ago that neuro would become a defining venture category!
You can have the right science and still run out of money at the wrong milestone.
Retsina Meyer (Delix Therapeutics) shows founders how to align development milestones with funding rounds. Future Neuro Founders, Oct 16.
Request to join: luma.com/3n0qbg05
Join us for our 3rd annual Future Neuro Founders Program co-hosted by PsyMed Ventures and KdT Ventures!
Last year 400+ founders from 190 universities joined our annual virtual, complimentary program again for scientists who want to build.
Whether you’re a researcher thinking about entrepreneurship or a founder early in their journey, this program will dive into how to transition from academia to building generational companies in neuro.
Request to join: luma.com/3n0qbg05
PsyMed Ventures retweeted
We wrote down why frontier neuroscience is finally investable: tech toolkit + pharma interest + multiple categories working at once. Our full map of what's becoming venture-backable, from BCIs to brain foundation models.
open.substack.com/pub/psymed…
Neuro was biotech's graveyard. Too complex, too slow, too many failures. Then everything changed.
@kubeans wrote about why the brain is finally investable and what comes next.
Full article here psymedventures.substack.com/…
We're back for another Frontier Neuro event at SF @deeptechweek this time with @E11BIO .
We'll have talks and networking about NeuroAI, whole-brain emulation, BCIs, and more.
Register Here: luma.com/3cuqfjso
Speakers in 🧵
@SumnerLN (@merge), @dileeplearning (@AsteraInstitute ), Alan Mardinly (@ScienceCorp_ ), and @JohanWinn (@E11BIO)
Neuro has become one of the defining fields of the next decade.
PsyMed Ventures retweeted
Human biology matters. Scientists and AI need human data to understand health and disease.
Crownlands is open sourcing Gateway 4M, the largest single-cell tissue dataset ever released from living humans, to advance research on brain aging and neurodegeneration.
PsyMed Ventures retweeted
1 month in space ages a brain organoid 10 years on Earth. Alysson Muotri's lab at UCSD is using this insight to study neurological disease. In our latest BT epi, we discuss aging the brain in orbit and what brain organoids might mean for the future of AI.
link in comments!
Designing the Ultimate Psychedelic Pill
Listen to the full episode:
businesstrip.fm/1173518/epis…
PsyMed Ventures retweeted
Gilgamesh sold a psychedelic drug to AbbVie for up to $1.2B.
We’ll look back on this as a landmark moment in psychedelic therapeutics and experiential therapies more broadly.
For the first time, Gilgamesh CEO & co-founder Jonathan talks on a podcast about the journey.
Listen: businesstrip.fm/1173518/epis…
NYC! Join us April 2 for a PsyMed Ventures neuro event, part of New York Deep Tech Week.
Featuring:
@MeganBlewett RNAi therapeutics & brain reprogramming
Dr. Ann DeSollar blindfold vision (+ live demo) @MindSeeIt
@BobbyKasthuri whole-brain emulation
RSVP in 🧵
20% of Mental Health Giving Came From Just 5 Funders!
Listen to the full episode:
businesstrip.fm/1173518/epis…